Latest cell therapy News

PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products
‘Flipping’ switch boosts stem cell numbers for therapies
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
Arovella receives commitments for $15 million following cancellation of January placement
Erling-Persson Foundation supports development of advanced cell therapy for Parkinson’s disease
Long-term survival following CAR T cell therapy to treat neuroblastoma
US University Joins Chimeric’s CHM CDH17 Clinical Trial
What you need to know about the new implants to patch up failing hearts – is it really a ‘breakthrough’?
Early Career Cancer Researcher Receives Funding
New research assists understanding of immune response to cancers, chronic disease
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
DoD grant funds innovative approach to fighting kidney cancer
More than SEK 80 million from the Swedish Childhood Cancer Foundation for KI projects
Anticancer drugs could make immunotherapies more effective
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Support for state-of-the-art cancer research projects
KI Research Presented To Eleven Nobel Laureates
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
Swedish Cancer Society grants SEK 23 million to MedH researchers
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
New study on microRNAs could lead to better fertility treatment
Stem cell therapy reverses type 1 diabetes in world first
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
Help Shape Future Of Bone Marrow Transplants
Chimeric announces new collaboration with Achieve Clinics
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing
Magellan Stem Cells welcomes $7m Australian Government grant
Balzan Prize 2024 For Lorraine Daston
New approach moves cell therapy closer to treating many disorders
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
New Treatment Hope For Perinatal Lung And Brain Injury
Baylor College of Medicine receives more than $17 million from CPRIT
Miles Government Unveils Queensland Cancer Plan
Chimeric Therapeutics says first patient enrolled in cell therapy trial
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
New Strategy Can Improve Cell Therapy Against Cancer
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
Research Funding For Ovarian Cancer Treatment
ACTION Centre to boost access to life-saving new therapies for children
AI Predicts Tumor-killing Cells With High Accuracy
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
Immune networks in tumors prime responses to a personalized immunotherapy
Arovella licences novel CARiNKT cell armouring technology
CAR T cell therapy for T cell lymphoma shows promise in phase I trial